Your browser doesn't support javascript.
loading
Analysis of Risk Factors for Developing Tuberculosis in Patients Who Received Prophylactic Latent Tuberculosis Infection Treatment with Experience of Biologic Medications.
Itagaki, Marina; Iketani, Osamu; Enoki, Yuki; Chuang, Victor Tuan Giam; Taguchi, Kazuaki; Uno, Shunsuke; Uchida, Sho; Namkoong, Ho; Uwamino, Yoshifumi; Takano, Yaoko; Hasegawa, Naoki; Matsumoto, Kazuaki.
Afiliação
  • Itagaki M; Division of Pharmacodynamics, Faculty of Pharmacy, Keio University.
  • Iketani O; Department of Infectious Diseases, Keio University School of Medicine.
  • Enoki Y; Division of Pharmacodynamics, Faculty of Pharmacy, Keio University.
  • Chuang VTG; Discipline of Pharmacy, Curtin Medical School, Faculty of Health Sciences, Curtin University.
  • Taguchi K; Division of Pharmacodynamics, Faculty of Pharmacy, Keio University.
  • Uno S; Department of Infectious Diseases, Keio University School of Medicine.
  • Uchida S; Department of Infectious Diseases, Keio University School of Medicine.
  • Namkoong H; Department of Infectious Diseases, Keio University School of Medicine.
  • Uwamino Y; Department of Infectious Diseases, Keio University School of Medicine.
  • Takano Y; Department of Infectious Diseases, Keio University School of Medicine.
  • Hasegawa N; Department of Infectious Diseases, Keio University School of Medicine.
  • Matsumoto K; Division of Pharmacodynamics, Faculty of Pharmacy, Keio University.
Biol Pharm Bull ; 46(12): 1832-1837, 2023.
Article em En | MEDLINE | ID: mdl-38044103

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Produtos Biológicos / Tuberculose Latente Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Produtos Biológicos / Tuberculose Latente Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article